Boston Business Journal
Wilmington-based Charles River Labs (NYSE: CRL) said Tuesday that it would pay $800 million in cash for MPI Research, a privately held firm headquartered in Mattawan, Michigan. It marks Charles River's second deal for a contract research organization, or CRO, so far this year. Such companies do not develop their own drugs, but are paid by drug developers to run clinical trials and provide other services.